secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001104659-24-112442
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BrainStorm regains Nasdaq minimum bid price compliance; listing continues
-------------------------------------------------------------------------

- Received Nasdaq notice of compliance on Oct 29, 2024; common stock continues on Nasdaq Capital Market.
- Effected 1-for-15 reverse stock split on Sep 30, 2024 to regain compliance.
- Stock closed above $1.00 for ten consecutive trading days as of Oct 15, 2024.
- Previously faced delisting; Nasdaq hearing panel granted temporary exception until Oct 21, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924112442/0001104659-24-112442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924112442/tm2427087d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-112442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer